EphB4 and ephrinB2 in Ovarian Cancers
Author Information
Author(s): Alam S M, Fujimoto J, Jahan I, Sato E, Tamaya T
Primary Institution: Gifu University School of Medicine
Hypothesis
The study investigates the role of EphB4 and ephrinB2 expressions in ovarian cancers and their correlation with clinical outcomes.
Conclusion
EphB4 and ephrinB2 coexpression may serve as a novel prognostic indicator in ovarian cancers, with high levels associated with poor survival rates.
Supporting Evidence
- EphB4 and ephrinB2 expressions significantly increased with clinical stages of ovarian cancer.
- Patients with high EphB4 and ephrinB2 expression had poor 24-month survival rates.
- Histoscores of EphB4 and ephrinB2 correlated with mRNA levels in cancer cells.
Takeaway
This study found that two proteins, EphB4 and ephrinB2, are linked to how bad ovarian cancer can get, and if you have a lot of them, you might not live as long.
Methodology
The study involved immunohistochemistry and real-time PCR to analyze EphB4 and ephrinB2 expressions in ovarian cancer tissues from 72 patients.
Limitations
The study did not assess the effects of preoperative therapy on the expression levels of EphB4 and ephrinB2.
Participant Demographics
Patients aged 45 to 79 years with various stages of ovarian cancer.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website